In vivo tests demonstrated that ZNNT1 could stop melanoma from growing in naked mice, and that ZNNT1's tumour suppressor effect could be somewhat mitigated by knocking down ATG12 (Li et al. 2020a). Here, ZNNT1 is linked to melanoma.